Celadon Pharmaceuticals Plc (AIM: CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 23.70
+2.20 (10.23%)
Jan 22, 2025, 11:53 AM GMT+1
Celadon Pharmaceuticals Revenue
Celadon Pharmaceuticals had revenue of 63.00K GBP in the half year ending June 30, 2024, with 472.73% growth. This brings the company's revenue in the last twelve months to 130.00K, up 519.05% year-over-year. In the year 2023, Celadon Pharmaceuticals had annual revenue of 75.00K with 212.50% growth.
Revenue (ttm)
130.00K
Revenue Growth
+519.05%
P/S Ratio
104.83
Revenue / Employee
4.81K
Employees
27
Market Cap
14.80M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |